These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24352471)

  • 21. Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.
    Tjiam MC; Taylor JP; Morshidi MA; Sariputra L; Burrows S; Martin JN; Deeks SG; Tan DB; Lee S; Fernandez S; French MA
    J Immunol; 2015 Jun; 194(11):5320-8. PubMed ID: 25911748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
    ; Pereyra F; Jia X; McLaren PJ; Telenti A; de Bakker PI; Walker BD; Ripke S; Brumme CJ; Pulit SL; Carrington M; Kadie CM; Carlson JM; Heckerman D; Graham RR; Plenge RM; Deeks SG; Gianniny L; Crawford G; Sullivan J; Gonzalez E; Davies L; Camargo A; Moore JM; Beattie N; Gupta S; Crenshaw A; Burtt NP; Guiducci C; Gupta N; Gao X; Qi Y; Yuki Y; Piechocka-Trocha A; Cutrell E; Rosenberg R; Moss KL; Lemay P; O'Leary J; Schaefer T; Verma P; Toth I; Block B; Baker B; Rothchild A; Lian J; Proudfoot J; Alvino DM; Vine S; Addo MM; Allen TM; Altfeld M; Henn MR; Le Gall S; Streeck H; Haas DW; Kuritzkes DR; Robbins GK; Shafer RW; Gulick RM; Shikuma CM; Haubrich R; Riddler S; Sax PE; Daar ES; Ribaudo HJ; Agan B; Agarwal S; Ahern RL; Allen BL; Altidor S; Altschuler EL; Ambardar S; Anastos K; Anderson B; Anderson V; Andrady U; Antoniskis D; Bangsberg D; Barbaro D; Barrie W; Bartczak J; Barton S; Basden P; Basgoz N; Bazner S; Bellos NC; Benson AM; Berger J; Bernard NF; Bernard AM; Birch C; Bodner SJ; Bolan RK; Boudreaux ET; Bradley M; Braun JF; Brndjar JE; Brown SJ; Brown K; Brown ST; Burack J; Bush LM; Cafaro V; Campbell O; Campbell J; Carlson RH; Carmichael JK; Casey KK; Cavacuiti C; Celestin G; Chambers ST; Chez N; Chirch LM; Cimoch PJ; Cohen D; Cohn LE; Conway B; Cooper DA; Cornelson B; Cox DT; Cristofano MV; Cuchural G; Czartoski JL; Dahman JM; Daly JS; Davis BT; Davis K; Davod SM; DeJesus E; Dietz CA; Dunham E; Dunn ME; Ellerin TB; Eron JJ; Fangman JJ; Farel CE; Ferlazzo H; Fidler S; Fleenor-Ford A; Frankel R; Freedberg KA; French NK; Fuchs JD; Fuller JD; Gaberman J; Gallant JE; Gandhi RT; Garcia E; Garmon D; Gathe JC; Gaultier CR; Gebre W; Gilman FD; Gilson I; Goepfert PA; Gottlieb MS; Goulston C; Groger RK; Gurley TD; Haber S; Hardwicke R; Hardy WD; Harrigan PR; Hawkins TN; Heath S; Hecht FM; Henry WK; Hladek M; Hoffman RP; Horton JM; Hsu RK; Huhn GD; Hunt P; Hupert MJ; Illeman ML; Jaeger H; Jellinger RM; John M; Johnson JA; Johnson KL; Johnson H; Johnson K; Joly J; Jordan WC; Kauffman CA; Khanlou H; Killian RK; Kim AY; Kim DD; Kinder CA; Kirchner JT; Kogelman L; Kojic EM; Korthuis PT; Kurisu W; Kwon DS; LaMar M; Lampiris H; Lanzafame M; Lederman MM; Lee DM; Lee JM; Lee MJ; Lee ET; Lemoine J; Levy JA; Llibre JM; Liguori MA; Little SJ; Liu AY; Lopez AJ; Loutfy MR; Loy D; Mohammed DY; Man A; Mansour MK; Marconi VC; Markowitz M; Marques R; Martin JN; Martin HL; Mayer KH; McElrath MJ; McGhee TA; McGovern BH; McGowan K; McIntyre D; Mcleod GX; Menezes P; Mesa G; Metroka CE; Meyer-Olson D; Miller AO; Montgomery K; Mounzer KC; Nagami EH; Nagin I; Nahass RG; Nelson MO; Nielsen C; Norene DL; O'Connor DH; Ojikutu BO; Okulicz J; Oladehin OO; Oldfield EC; Olender SA; Ostrowski M; Owen WF; Pae E; Parsonnet J; Pavlatos AM; Perlmutter AM; Pierce MN; Pincus JM; Pisani L; Price LJ; Proia L; Prokesch RC; Pujet HC; Ramgopal M; Rathod A; Rausch M; Ravishankar J; Rhame FS; Richards CS; Richman DD; Rodes B; Rodriguez M; Rose RC; Rosenberg ES; Rosenthal D; Ross PE; Rubin DS; Rumbaugh E; Saenz L; Salvaggio MR; Sanchez WC; Sanjana VM; Santiago S; Schmidt W; Schuitemaker H; Sestak PM; Shalit P; Shay W; Shirvani VN; Silebi VI; Sizemore JM; Skolnik PR; Sokol-Anderson M; Sosman JM; Stabile P; Stapleton JT; Starrett S; Stein F; Stellbrink HJ; Sterman FL; Stone VE; Stone DR; Tambussi G; Taplitz RA; Tedaldi EM; Telenti A; Theisen W; Torres R; Tosiello L; Tremblay C; Tribble MA; Trinh PD; Tsao A; Ueda P; Vaccaro A; Valadas E; Vanig TJ; Vecino I; Vega VM; Veikley W; Wade BH; Walworth C; Wanidworanun C; Ward DJ; Warner DA; Weber RD; Webster D; Weis S; Wheeler DA; White DJ; Wilkins E; Winston A; Wlodaver CG; van't Wout A; Wright DP; Yang OO; Yurdin DL; Zabukovic BW; Zachary KC; Zeeman B; Zhao M
    Science; 2010 Dec; 330(6010):1551-7. PubMed ID: 21051598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.
    Descours B; Avettand-Fenoel V; Blanc C; Samri A; Mélard A; Supervie V; Theodorou I; Carcelain G; Rouzioux C; Autran B;
    Clin Infect Dis; 2012 May; 54(10):1495-503. PubMed ID: 22441653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control.
    Ackerman ME; Mikhailova A; Brown EP; Dowell KG; Walker BD; Bailey-Kellogg C; Suscovich TJ; Alter G
    PLoS Pathog; 2016 Jan; 12(1):e1005315. PubMed ID: 26745376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
    Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
    AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct antibody profiles in HLA-B∗57+, HLA-B∗57- HIV controllers and chronic progressors.
    Klingler J; Paul N; Laumond G; Schmidt S; Mayr LM; Decoville T; Lambotte O; Autran B; Bahram S; Moog C;
    AIDS; 2022 Mar; 36(4):487-499. PubMed ID: 34581307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
    Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
    Front Immunol; 2020; 11():1274. PubMed ID: 32733445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo.
    Wang P; Gajjar MR; Yu J; Padte NN; Gettie A; Blanchard JL; Russell-Lodrigue K; Liao LE; Perelson AS; Huang Y; Ho DD
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18002-18009. PubMed ID: 32665438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome.
    Carapito R; Mayr L; Molitor A; Verniquet M; Schmidt S; Tahar O; Partisani M; Rey D; Lambotte O; Bahram S; Moog C
    Genes Immun; 2020 Aug; 21(4):263-268. PubMed ID: 32759994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
    Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L
    PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.
    Lassaunière R; Musekiwa A; Gray GE; Kuhn L; Tiemessen CT
    Retrovirology; 2016 Jun; 13(1):40. PubMed ID: 27287460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems serology for evaluation of HIV vaccine trials.
    Ackerman ME; Barouch DH; Alter G
    Immunol Rev; 2017 Jan; 275(1):262-270. PubMed ID: 28133810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.